Beta-sitosterol vs saw palmetto: which is better for the prostate?

Last updated: June 2026 · Reviewed by the FactoWiki Editorial Team for clarity and source accuracy

Written by FactoWiki Research Team · Reviewed by Supplement Research Editor

Last reviewed: June 2026 · Sources checked: PubMed, NIH, MedlinePlus, NCCIH, FDA

A head-to-head on the two big prostate ingredients — which has the evidence, and what neither can do.

Key takeaways

Beta-sitosterol has more consistent evidence for urinary symptoms than saw palmetto.
Large trials found saw palmetto no better than placebo, despite its fame.
Neither shrinks the prostate or cures anything — they may ease symptoms at most.

Why this comparison matters

Beta-sitosterol and saw palmetto are the two ingredients you'll meet most often in prostate supplements, frequently in the same formula. They're aimed at the same thing — the urinary symptoms of an enlarging prostate — but the evidence behind them is very different, and which one a product leads with tells you a lot about how seriously it took the research.

Saw palmetto: famous but unconvincing

Saw palmetto is the better-known of the two, riding on early small studies and long traditional use. But when tested in large, rigorous randomised trials, including at higher doses, it performed no better than placebo for urinary symptoms. It's not harmful, but the strong evidence simply doesn't support meaningful benefit — a clear gap between reputation and reality.

Beta-sitosterol: the better-evidenced choice

Beta-sitosterol, a plant sterol, has more consistent research for easing urinary flow and symptoms — some of the better evidence in this whole category. The studied range is roughly 60–130 mg/day, so a product that discloses its beta-sitosterol dose is more trustworthy than one hiding it. On the evidence, it's the ingredient worth prioritising, which is the opposite of what the marketing emphasis usually suggests.

What neither one does

It's important to be clear about the shared ceiling: neither beta-sitosterol nor saw palmetto shrinks the prostate or treats the underlying enlargement. At best they may ease symptoms for some men while the cause is managed. Pygeum and stinging nettle, the other common stack ingredients, sit in a similar place — possible modest symptom relief, no cure.

How to read a label

Put two prostate products side by side and check which ingredient they emphasise and disclose. A formula that headlines saw palmetto while burying or omitting beta-sitosterol is leading with the weaker ingredient. One that discloses a researched beta-sitosterol dose is better-founded. As always, a proprietary blend that hides individual amounts makes this impossible to judge — itself a reason for caution.

The bottom line

On the best evidence, beta-sitosterol beats saw palmetto for urinary symptoms — but both only ease symptoms at most, and neither is a cure. If you're choosing, favour a product with a disclosed beta-sitosterol dose, keep expectations modest, and get urinary symptoms assessed by a doctor first, since they can have causes that need proper attention.

Related guides

Ingredient

ProstaVive

Frequently asked questions

Is beta-sitosterol better than saw palmetto?

On the evidence, yes — beta-sitosterol has more consistent research for urinary symptoms, while saw palmetto failed large trials.

Should a prostate supplement contain both?

Many do, but it's beta-sitosterol that carries the better evidence; check that its dose is disclosed.

Do these shrink the prostate?

No. At best they may ease urinary symptoms for some men — neither shrinks the prostate or cures anything.

What dose of beta-sitosterol is used in studies?

Roughly 60–130 mg/day, so look for a product that discloses its amount.

This article is general information, not medical advice. See our medical disclaimer, and talk to a qualified healthcare professional about your own situation.